Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0S6AQ
|
||||
Former ID |
DIB000800
|
||||
Drug Name |
Ramorelix
|
||||
Synonyms |
Hoe-013
|
||||
Indication | Esophageal cancer [ICD9: 150; ICD10:C15] | Discontinued in Phase 1 | [546504] | ||
Company |
Aventis Pharma AG
|
||||
Structure |
Download2D MOL |
||||
Formula |
C74H95ClN16O18
|
||||
Canonical SMILES |
N1(C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC<br />(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@H](NC(=O)[C@H](NC(=O)C)<br />Cc2cc3c(cc2)cccc3)Cc2ccc(Cl)cc2)Cc2c[nH]c3c2cccc3)CO)Cc<br />2ccc(cc2)O)CO[C@H]2[C@@H]([C@@H]([C@H]([C@@H](O2)C)O)O)<br />O)CC(C)C)CCCNC(=N)N)[C@H](C(=O)NNC(=O)N)CCC1
|
||||
CAS Number |
CAS 127932-90-5
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Gonadotropin-releasing hormone receptor | Target Info | Antagonist | [534062] | |
NetPath Pathway | IL1 Signaling Pathway | ||||
IL2 Signaling Pathway | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.